Global Streptococcus Pneumoniae Vaccine Market Growth 2023-2028

Report ID: 1479600 | Published Date: Oct 2024 | No. of Page: 129 | Base Year: 2023 | Rating: 4.2 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Scope of the Report
    1.1 Market Introduction
    1.2 Years Considered
    1.3 Research Objectives
    1.4 Market Research Methodology
    1.5 Research Process and Data Source
    1.6 Economic Indicators
    1.7 Currency Considered
2 Executive Summary
    2.1 World Market Overview
        2.1.1 Global Streptococcus Pneumoniae Vaccine Annual Sales 2017-2028
        2.1.2 World Current & Future Analysis for Streptococcus Pneumoniae Vaccine by Geographic Region, 2017, 2022 & 2028
        2.1.3 World Current & Future Analysis for Streptococcus Pneumoniae Vaccine by Country/Region, 2017, 2022 & 2028
    2.2 Streptococcus Pneumoniae Vaccine Segment by Type
        2.2.1 7 -Valent
        2.2.2 10 -Valent
        2.2.3 13 -Valent
        2.2.4 15 -Valent
        2.2.5 23 -Valent
        2.2.6 Other
    2.3 Streptococcus Pneumoniae Vaccine Sales by Type
        2.3.1 Global Streptococcus Pneumoniae Vaccine Sales Market Share by Type (2017-2022)
        2.3.2 Global Streptococcus Pneumoniae Vaccine Revenue and Market Share by Type (2017-2022)
        2.3.3 Global Streptococcus Pneumoniae Vaccine Sale Price by Type (2017-2022)
    2.4 Streptococcus Pneumoniae Vaccine Segment by Application
        2.4.1 Children under 2 Years of Age
        2.4.2 Adults over 65 Years of Age
        2.4.3 Addicted Smokers Between the Ages of 19 and 64
        2.4.4 Other
    2.5 Streptococcus Pneumoniae Vaccine Sales by Application
        2.5.1 Global Streptococcus Pneumoniae Vaccine Sale Market Share by Application (2017-2022)
        2.5.2 Global Streptococcus Pneumoniae Vaccine Revenue and Market Share by Application (2017-2022)
        2.5.3 Global Streptococcus Pneumoniae Vaccine Sale Price by Application (2017-2022)
3 Global Streptococcus Pneumoniae Vaccine by Company
    3.1 Global Streptococcus Pneumoniae Vaccine Breakdown Data by Company
        3.1.1 Global Streptococcus Pneumoniae Vaccine Annual Sales by Company (2020-2022)
        3.1.2 Global Streptococcus Pneumoniae Vaccine Sales Market Share by Company (2020-2022)
    3.2 Global Streptococcus Pneumoniae Vaccine Annual Revenue by Company (2020-2022)
        3.2.1 Global Streptococcus Pneumoniae Vaccine Revenue by Company (2020-2022)
        3.2.2 Global Streptococcus Pneumoniae Vaccine Revenue Market Share by Company (2020-2022)
    3.3 Global Streptococcus Pneumoniae Vaccine Sale Price by Company
    3.4 Key Manufacturers Streptococcus Pneumoniae Vaccine Producing Area Distribution, Sales Area, Product Type
        3.4.1 Key Manufacturers Streptococcus Pneumoniae Vaccine Product Location Distribution
        3.4.2 Players Streptococcus Pneumoniae Vaccine Products Offered
    3.5 Market Concentration Rate Analysis
        3.5.1 Competition Landscape Analysis
        3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    3.6 New Products and Potential Entrants
    3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Streptococcus Pneumoniae Vaccine by Geographic Region
    4.1 World Historic Streptococcus Pneumoniae Vaccine Market Size by Geographic Region (2017-2022)
        4.1.1 Global Streptococcus Pneumoniae Vaccine Annual Sales by Geographic Region (2017-2022)
        4.1.2 Global Streptococcus Pneumoniae Vaccine Annual Revenue by Geographic Region
    4.2 World Historic Streptococcus Pneumoniae Vaccine Market Size by Country/Region (2017-2022)
        4.2.1 Global Streptococcus Pneumoniae Vaccine Annual Sales by Country/Region (2017-2022)
        4.2.2 Global Streptococcus Pneumoniae Vaccine Annual Revenue by Country/Region
    4.3 Americas Streptococcus Pneumoniae Vaccine Sales Growth
    4.4 APAC Streptococcus Pneumoniae Vaccine Sales Growth
    4.5 Europe Streptococcus Pneumoniae Vaccine Sales Growth
    4.6 Middle East & Africa Streptococcus Pneumoniae Vaccine Sales Growth
5 Americas
    5.1 Americas Streptococcus Pneumoniae Vaccine Sales by Country
        5.1.1 Americas Streptococcus Pneumoniae Vaccine Sales by Country (2017-2022)
        5.1.2 Americas Streptococcus Pneumoniae Vaccine Revenue by Country (2017-2022)
    5.2 Americas Streptococcus Pneumoniae Vaccine Sales by Type
    5.3 Americas Streptococcus Pneumoniae Vaccine Sales by Application
    5.4 United States
    5.5 Canada
    5.6 Mexico
    5.7 Brazil
6 APAC
    6.1 APAC Streptococcus Pneumoniae Vaccine Sales by Region
        6.1.1 APAC Streptococcus Pneumoniae Vaccine Sales by Region (2017-2022)
        6.1.2 APAC Streptococcus Pneumoniae Vaccine Revenue by Region (2017-2022)
    6.2 APAC Streptococcus Pneumoniae Vaccine Sales by Type
    6.3 APAC Streptococcus Pneumoniae Vaccine Sales by Application
    6.4 China
    6.5 Japan
    6.6 South Korea
    6.7 Southeast Asia
    6.8 India
    6.9 Australia
    6.10 China Taiwan
7 Europe
    7.1 Europe Streptococcus Pneumoniae Vaccine by Country
        7.1.1 Europe Streptococcus Pneumoniae Vaccine Sales by Country (2017-2022)
        7.1.2 Europe Streptococcus Pneumoniae Vaccine Revenue by Country (2017-2022)
    7.2 Europe Streptococcus Pneumoniae Vaccine Sales by Type
    7.3 Europe Streptococcus Pneumoniae Vaccine Sales by Application
    7.4 Germany
    7.5 France
    7.6 UK
    7.7 Italy
    7.8 Russia
8 Middle East & Africa
    8.1 Middle East & Africa Streptococcus Pneumoniae Vaccine by Country
        8.1.1 Middle East & Africa Streptococcus Pneumoniae Vaccine Sales by Country (2017-2022)
        8.1.2 Middle East & Africa Streptococcus Pneumoniae Vaccine Revenue by Country (2017-2022)
    8.2 Middle East & Africa Streptococcus Pneumoniae Vaccine Sales by Type
    8.3 Middle East & Africa Streptococcus Pneumoniae Vaccine Sales by Application
    8.4 Egypt
    8.5 South Africa
    8.6 Israel
    8.7 Turkey
    8.8 GCC Countries
9 Market Drivers, Challenges and Trends
    9.1 Market Drivers & Growth Opportunities
    9.2 Market Challenges & Risks
    9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
    10.1 Raw Material and Suppliers
    10.2 Manufacturing Cost Structure Analysis of Streptococcus Pneumoniae Vaccine
    10.3 Manufacturing Process Analysis of Streptococcus Pneumoniae Vaccine
    10.4 Industry Chain Structure of Streptococcus Pneumoniae Vaccine
11 Marketing, Distributors and Customer
    11.1 Sales Channel
        11.1.1 Direct Channels
        11.1.2 Indirect Channels
    11.2 Streptococcus Pneumoniae Vaccine Distributors
    11.3 Streptococcus Pneumoniae Vaccine Customer
12 World Forecast Review for Streptococcus Pneumoniae Vaccine by Geographic Region
    12.1 Global Streptococcus Pneumoniae Vaccine Market Size Forecast by Region
        12.1.1 Global Streptococcus Pneumoniae Vaccine Forecast by Region (2023-2028)
        12.1.2 Global Streptococcus Pneumoniae Vaccine Annual Revenue Forecast by Region (2023-2028)
    12.2 Americas Forecast by Country
    12.3 APAC Forecast by Region
    12.4 Europe Forecast by Country
    12.5 Middle East & Africa Forecast by Country
    12.6 Global Streptococcus Pneumoniae Vaccine Forecast by Type
    12.7 Global Streptococcus Pneumoniae Vaccine Forecast by Application
13 Key Players Analysis
    13.1 Pfizer
        13.1.1 Pfizer Company Information
        13.1.2 Pfizer Streptococcus Pneumoniae Vaccine Product Offered
        13.1.3 Pfizer Streptococcus Pneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
        13.1.4 Pfizer Main Business Overview
        13.1.5 Pfizer Latest Developments
    13.2 Sanofi
        13.2.1 Sanofi Company Information
        13.2.2 Sanofi Streptococcus Pneumoniae Vaccine Product Offered
        13.2.3 Sanofi Streptococcus Pneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
        13.2.4 Sanofi Main Business Overview
        13.2.5 Sanofi Latest Developments
    13.3 GSK
        13.3.1 GSK Company Information
        13.3.2 GSK Streptococcus Pneumoniae Vaccine Product Offered
        13.3.3 GSK Streptococcus Pneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
        13.3.4 GSK Main Business Overview
        13.3.5 GSK Latest Developments
    13.4 Merck
        13.4.1 Merck Company Information
        13.4.2 Merck Streptococcus Pneumoniae Vaccine Product Offered
        13.4.3 Merck Streptococcus Pneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
        13.4.4 Merck Main Business Overview
        13.4.5 Merck Latest Developments
    13.5 Eli Lilly
        13.5.1 Eli Lilly Company Information
        13.5.2 Eli Lilly Streptococcus Pneumoniae Vaccine Product Offered
        13.5.3 Eli Lilly Streptococcus Pneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
        13.5.4 Eli Lilly Main Business Overview
        13.5.5 Eli Lilly Latest Developments
    13.6 AstraZeneca
        13.6.1 AstraZeneca Company Information
        13.6.2 AstraZeneca Streptococcus Pneumoniae Vaccine Product Offered
        13.6.3 AstraZeneca Streptococcus Pneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
        13.6.4 AstraZeneca Main Business Overview
        13.6.5 AstraZeneca Latest Developments
    13.7 Abera
        13.7.1 Abera Company Information
        13.7.2 Abera Streptococcus Pneumoniae Vaccine Product Offered
        13.7.3 Abera Streptococcus Pneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
        13.7.4 Abera Main Business Overview
        13.7.5 Abera Latest Developments
    13.8 S K Chemicals
        13.8.1 S K Chemicals Company Information
        13.8.2 S K Chemicals Streptococcus Pneumoniae Vaccine Product Offered
        13.8.3 S K Chemicals Streptococcus Pneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
        13.8.4 S K Chemicals Main Business Overview
        13.8.5 S K Chemicals Latest Developments
    13.9 Beijing Minhai Biotechnology
        13.9.1 Beijing Minhai Biotechnology Company Information
        13.9.2 Beijing Minhai Biotechnology Streptococcus Pneumoniae Vaccine Product Offered
        13.9.3 Beijing Minhai Biotechnology Streptococcus Pneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
        13.9.4 Beijing Minhai Biotechnology Main Business Overview
        13.9.5 Beijing Minhai Biotechnology Latest Developments
    13.10 Baxter
        13.10.1 Baxter Company Information
        13.10.2 Baxter Streptococcus Pneumoniae Vaccine Product Offered
        13.10.3 Baxter Streptococcus Pneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
        13.10.4 Baxter Main Business Overview
        13.10.5 Baxter Latest Developments
    13.11 Biken
        13.11.1 Biken Company Information
        13.11.2 Biken Streptococcus Pneumoniae Vaccine Product Offered
        13.11.3 Biken Streptococcus Pneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
        13.11.4 Biken Main Business Overview
        13.11.5 Biken Latest Developments
    13.12 Celgene Corporation
        13.12.1 Celgene Corporation Company Information
        13.12.2 Celgene Corporation Streptococcus Pneumoniae Vaccine Product Offered
        13.12.3 Celgene Corporation Streptococcus Pneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
        13.12.4 Celgene Corporation Main Business Overview
        13.12.5 Celgene Corporation Latest Developments
    13.13 Panacea Biotec
        13.13.1 Panacea Biotec Company Information
        13.13.2 Panacea Biotec Streptococcus Pneumoniae Vaccine Product Offered
        13.13.3 Panacea Biotec Streptococcus Pneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
        13.13.4 Panacea Biotec Main Business Overview
        13.13.5 Panacea Biotec Latest Developments
    13.14 Serum Institute of India
        13.14.1 Serum Institute of India Company Information
        13.14.2 Serum Institute of India Streptococcus Pneumoniae Vaccine Product Offered
        13.14.3 Serum Institute of India Streptococcus Pneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
        13.14.4 Serum Institute of India Main Business Overview
        13.14.5 Serum Institute of India Latest Developments
    13.15 Genentech
        13.15.1 Genentech Company Information
        13.15.2 Genentech Streptococcus Pneumoniae Vaccine Product Offered
        13.15.3 Genentech Streptococcus Pneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
        13.15.4 Genentech Main Business Overview
        13.15.5 Genentech Latest Developments
    13.16 Genocea Biosciences
        13.16.1 Genocea Biosciences Company Information
        13.16.2 Genocea Biosciences Streptococcus Pneumoniae Vaccine Product Offered
        13.16.3 Genocea Biosciences Streptococcus Pneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
        13.16.4 Genocea Biosciences Main Business Overview
        13.16.5 Genocea Biosciences Latest Developments
    13.17 ImmunoBiology
        13.17.1 ImmunoBiology Company Information
        13.17.2 ImmunoBiology Streptococcus Pneumoniae Vaccine Product Offered
        13.17.3 ImmunoBiology Streptococcus Pneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
        13.17.4 ImmunoBiology Main Business Overview
        13.17.5 ImmunoBiology Latest Developments
    13.18 Lupin
        13.18.1 Lupin Company Information
        13.18.2 Lupin Streptococcus Pneumoniae Vaccine Product Offered
        13.18.3 Lupin Streptococcus Pneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
        13.18.4 Lupin Main Business Overview
        13.18.5 Lupin Latest Developments
    13.19 Nuron Biotech
        13.19.1 Nuron Biotech Company Information
        13.19.2 Nuron Biotech Streptococcus Pneumoniae Vaccine Product Offered
        13.19.3 Nuron Biotech Streptococcus Pneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
        13.19.4 Nuron Biotech Main Business Overview
        13.19.5 Nuron Biotech Latest Developments
    13.20 Biogen
        13.20.1 Biogen Company Information
        13.20.2 Biogen Streptococcus Pneumoniae Vaccine Product Offered
        13.20.3 Biogen Streptococcus Pneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
        13.20.4 Biogen Main Business Overview
        13.20.5 Biogen Latest Developments
    13.21 Valneva Austria
        13.21.1 Valneva Austria Company Information
        13.21.2 Valneva Austria Streptococcus Pneumoniae Vaccine Product Offered
        13.21.3 Valneva Austria Streptococcus Pneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
        13.21.4 Valneva Austria Main Business Overview
        13.21.5 Valneva Austria Latest Developments
    13.22 Sinovac
        13.22.1 Sinovac Company Information
        13.22.2 Sinovac Streptococcus Pneumoniae Vaccine Product Offered
        13.22.3 Sinovac Streptococcus Pneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
        13.22.4 Sinovac Main Business Overview
        13.22.5 Sinovac Latest Developments
14 Research Findings and Conclusion

List of Tables
    Table 1. Streptococcus Pneumoniae Vaccine Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
    Table 2. Streptococcus Pneumoniae Vaccine Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
    Table 3. Major Players of 7 -Valent
    Table 4. Major Players of 10 -Valent
    Table 5. Major Players of 13 -Valent
    Table 6. Major Players of 15 -Valent
    Table 7. Major Players of 23 -Valent
    Table 8. Major Players of Other
    Table 9. Global Streptococcus Pneumoniae Vaccine Sales by Type (2017-2022) & (K Units)
    Table 10. Global Streptococcus Pneumoniae Vaccine Sales Market Share by Type (2017-2022)
    Table 11. Global Streptococcus Pneumoniae Vaccine Revenue by Type (2017-2022) & ($ million)
    Table 12. Global Streptococcus Pneumoniae Vaccine Revenue Market Share by Type (2017-2022)
    Table 13. Global Streptococcus Pneumoniae Vaccine Sale Price by Type (2017-2022) & (US$/Unit)
    Table 14. Global Streptococcus Pneumoniae Vaccine Sales by Application (2017-2022) & (K Units)
    Table 15. Global Streptococcus Pneumoniae Vaccine Sales Market Share by Application (2017-2022)
    Table 16. Global Streptococcus Pneumoniae Vaccine Revenue by Application (2017-2022)
    Table 17. Global Streptococcus Pneumoniae Vaccine Revenue Market Share by Application (2017-2022)
    Table 18. Global Streptococcus Pneumoniae Vaccine Sale Price by Application (2017-2022) & (US$/Unit)
    Table 19. Global Streptococcus Pneumoniae Vaccine Sales by Company (2020-2022) & (K Units)
    Table 20. Global Streptococcus Pneumoniae Vaccine Sales Market Share by Company (2020-2022)
    Table 21. Global Streptococcus Pneumoniae Vaccine Revenue by Company (2020-2022) ($ Millions)
    Table 22. Global Streptococcus Pneumoniae Vaccine Revenue Market Share by Company (2020-2022)
    Table 23. Global Streptococcus Pneumoniae Vaccine Sale Price by Company (2020-2022) & (US$/Unit)
    Table 24. Key Manufacturers Streptococcus Pneumoniae Vaccine Producing Area Distribution and Sales Area
    Table 25. Players Streptococcus Pneumoniae Vaccine Products Offered
    Table 26. Streptococcus Pneumoniae Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    Table 27. New Products and Potential Entrants
    Table 28. Mergers & Acquisitions, Expansion
    Table 29. Global Streptococcus Pneumoniae Vaccine Sales by Geographic Region (2017-2022) & (K Units)
    Table 30. Global Streptococcus Pneumoniae Vaccine Sales Market Share Geographic Region (2017-2022)
    Table 31. Global Streptococcus Pneumoniae Vaccine Revenue by Geographic Region (2017-2022) & ($ millions)
    Table 32. Global Streptococcus Pneumoniae Vaccine Revenue Market Share by Geographic Region (2017-2022)
    Table 33. Global Streptococcus Pneumoniae Vaccine Sales by Country/Region (2017-2022) & (K Units)
    Table 34. Global Streptococcus Pneumoniae Vaccine Sales Market Share by Country/Region (2017-2022)
    Table 35. Global Streptococcus Pneumoniae Vaccine Revenue by Country/Region (2017-2022) & ($ millions)
    Table 36. Global Streptococcus Pneumoniae Vaccine Revenue Market Share by Country/Region (2017-2022)
    Table 37. Americas Streptococcus Pneumoniae Vaccine Sales by Country (2017-2022) & (K Units)
    Table 38. Americas Streptococcus Pneumoniae Vaccine Sales Market Share by Country (2017-2022)
    Table 39. Americas Streptococcus Pneumoniae Vaccine Revenue by Country (2017-2022) & ($ Millions)
    Table 40. Americas Streptococcus Pneumoniae Vaccine Revenue Market Share by Country (2017-2022)
    Table 41. Americas Streptococcus Pneumoniae Vaccine Sales by Type (2017-2022) & (K Units)
    Table 42. Americas Streptococcus Pneumoniae Vaccine Sales Market Share by Type (2017-2022)
    Table 43. Americas Streptococcus Pneumoniae Vaccine Sales by Application (2017-2022) & (K Units)
    Table 44. Americas Streptococcus Pneumoniae Vaccine Sales Market Share by Application (2017-2022)
    Table 45. APAC Streptococcus Pneumoniae Vaccine Sales by Region (2017-2022) & (K Units)
    Table 46. APAC Streptococcus Pneumoniae Vaccine Sales Market Share by Region (2017-2022)
    Table 47. APAC Streptococcus Pneumoniae Vaccine Revenue by Region (2017-2022) & ($ Millions)
    Table 48. APAC Streptococcus Pneumoniae Vaccine Revenue Market Share by Region (2017-2022)
    Table 49. APAC Streptococcus Pneumoniae Vaccine Sales by Type (2017-2022) & (K Units)
    Table 50. APAC Streptococcus Pneumoniae Vaccine Sales Market Share by Type (2017-2022)
    Table 51. APAC Streptococcus Pneumoniae Vaccine Sales by Application (2017-2022) & (K Units)
    Table 52. APAC Streptococcus Pneumoniae Vaccine Sales Market Share by Application (2017-2022)
    Table 53. Europe Streptococcus Pneumoniae Vaccine Sales by Country (2017-2022) & (K Units)
    Table 54. Europe Streptococcus Pneumoniae Vaccine Sales Market Share by Country (2017-2022)
    Table 55. Europe Streptococcus Pneumoniae Vaccine Revenue by Country (2017-2022) & ($ Millions)
    Table 56. Europe Streptococcus Pneumoniae Vaccine Revenue Market Share by Country (2017-2022)
    Table 57. Europe Streptococcus Pneumoniae Vaccine Sales by Type (2017-2022) & (K Units)
    Table 58. Europe Streptococcus Pneumoniae Vaccine Sales Market Share by Type (2017-2022)
    Table 59. Europe Streptococcus Pneumoniae Vaccine Sales by Application (2017-2022) & (K Units)
    Table 60. Europe Streptococcus Pneumoniae Vaccine Sales Market Share by Application (2017-2022)
    Table 61. Middle East & Africa Streptococcus Pneumoniae Vaccine Sales by Country (2017-2022) & (K Units)
    Table 62. Middle East & Africa Streptococcus Pneumoniae Vaccine Sales Market Share by Country (2017-2022)
    Table 63. Middle East & Africa Streptococcus Pneumoniae Vaccine Revenue by Country (2017-2022) & ($ Millions)
    Table 64. Middle East & Africa Streptococcus Pneumoniae Vaccine Revenue Market Share by Country (2017-2022)
    Table 65. Middle East & Africa Streptococcus Pneumoniae Vaccine Sales by Type (2017-2022) & (K Units)
    Table 66. Middle East & Africa Streptococcus Pneumoniae Vaccine Sales Market Share by Type (2017-2022)
    Table 67. Middle East & Africa Streptococcus Pneumoniae Vaccine Sales by Application (2017-2022) & (K Units)
    Table 68. Middle East & Africa Streptococcus Pneumoniae Vaccine Sales Market Share by Application (2017-2022)
    Table 69. Key Market Drivers & Growth Opportunities of Streptococcus Pneumoniae Vaccine
    Table 70. Key Market Challenges & Risks of Streptococcus Pneumoniae Vaccine
    Table 71. Key Industry Trends of Streptococcus Pneumoniae Vaccine
    Table 72. Streptococcus Pneumoniae Vaccine Raw Material
    Table 73. Key Suppliers of Raw Materials
    Table 74. Streptococcus Pneumoniae Vaccine Distributors List
    Table 75. Streptococcus Pneumoniae Vaccine Customer List
    Table 76. Global Streptococcus Pneumoniae Vaccine Sales Forecast by Region (2023-2028) & (K Units)
    Table 77. Global Streptococcus Pneumoniae Vaccine Sales Market Forecast by Region
    Table 78. Global Streptococcus Pneumoniae Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)
    Table 79. Global Streptococcus Pneumoniae Vaccine Revenue Market Share Forecast by Region (2023-2028)
    Table 80. Americas Streptococcus Pneumoniae Vaccine Sales Forecast by Country (2023-2028) & (K Units)
    Table 81. Americas Streptococcus Pneumoniae Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 82. APAC Streptococcus Pneumoniae Vaccine Sales Forecast by Region (2023-2028) & (K Units)
    Table 83. APAC Streptococcus Pneumoniae Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)
    Table 84. Europe Streptococcus Pneumoniae Vaccine Sales Forecast by Country (2023-2028) & (K Units)
    Table 85. Europe Streptococcus Pneumoniae Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 86. Middle East & Africa Streptococcus Pneumoniae Vaccine Sales Forecast by Country (2023-2028) & (K Units)
    Table 87. Middle East & Africa Streptococcus Pneumoniae Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 88. Global Streptococcus Pneumoniae Vaccine Sales Forecast by Type (2023-2028) & (K Units)
    Table 89. Global Streptococcus Pneumoniae Vaccine Sales Market Share Forecast by Type (2023-2028)
    Table 90. Global Streptococcus Pneumoniae Vaccine Revenue Forecast by Type (2023-2028) & ($ Millions)
    Table 91. Global Streptococcus Pneumoniae Vaccine Revenue Market Share Forecast by Type (2023-2028)
    Table 92. Global Streptococcus Pneumoniae Vaccine Sales Forecast by Application (2023-2028) & (K Units)
    Table 93. Global Streptococcus Pneumoniae Vaccine Sales Market Share Forecast by Application (2023-2028)
    Table 94. Global Streptococcus Pneumoniae Vaccine Revenue Forecast by Application (2023-2028) & ($ Millions)
    Table 95. Global Streptococcus Pneumoniae Vaccine Revenue Market Share Forecast by Application (2023-2028)
    Table 96. Pfizer Basic Information, Streptococcus Pneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors
    Table 97. Pfizer Streptococcus Pneumoniae Vaccine Product Offered
    Table 98. Pfizer Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 99. Pfizer Main Business
    Table 100. Pfizer Latest Developments
    Table 101. Sanofi Basic Information, Streptococcus Pneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors
    Table 102. Sanofi Streptococcus Pneumoniae Vaccine Product Offered
    Table 103. Sanofi Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 104. Sanofi Main Business
    Table 105. Sanofi Latest Developments
    Table 106. GSK Basic Information, Streptococcus Pneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors
    Table 107. GSK Streptococcus Pneumoniae Vaccine Product Offered
    Table 108. GSK Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 109. GSK Main Business
    Table 110. GSK Latest Developments
    Table 111. Merck Basic Information, Streptococcus Pneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors
    Table 112. Merck Streptococcus Pneumoniae Vaccine Product Offered
    Table 113. Merck Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 114. Merck Main Business
    Table 115. Merck Latest Developments
    Table 116. Eli Lilly Basic Information, Streptococcus Pneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors
    Table 117. Eli Lilly Streptococcus Pneumoniae Vaccine Product Offered
    Table 118. Eli Lilly Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 119. Eli Lilly Main Business
    Table 120. Eli Lilly Latest Developments
    Table 121. AstraZeneca Basic Information, Streptococcus Pneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors
    Table 122. AstraZeneca Streptococcus Pneumoniae Vaccine Product Offered
    Table 123. AstraZeneca Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 124. AstraZeneca Main Business
    Table 125. AstraZeneca Latest Developments
    Table 126. Abera Basic Information, Streptococcus Pneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors
    Table 127. Abera Streptococcus Pneumoniae Vaccine Product Offered
    Table 128. Abera Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 129. Abera Main Business
    Table 130. Abera Latest Developments
    Table 131. S K Chemicals Basic Information, Streptococcus Pneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors
    Table 132. S K Chemicals Streptococcus Pneumoniae Vaccine Product Offered
    Table 133. S K Chemicals Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 134. S K Chemicals Main Business
    Table 135. S K Chemicals Latest Developments
    Table 136. Beijing Minhai Biotechnology Basic Information, Streptococcus Pneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors
    Table 137. Beijing Minhai Biotechnology Streptococcus Pneumoniae Vaccine Product Offered
    Table 138. Beijing Minhai Biotechnology Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 139. Beijing Minhai Biotechnology Main Business
    Table 140. Beijing Minhai Biotechnology Latest Developments
    Table 141. Baxter Basic Information, Streptococcus Pneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors
    Table 142. Baxter Streptococcus Pneumoniae Vaccine Product Offered
    Table 143. Baxter Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 144. Baxter Main Business
    Table 145. Baxter Latest Developments
    Table 146. Biken Basic Information, Streptococcus Pneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors
    Table 147. Biken Streptococcus Pneumoniae Vaccine Product Offered
    Table 148. Biken Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 149. Biken Main Business
    Table 150. Biken Latest Developments
    Table 151. Celgene Corporation Basic Information, Streptococcus Pneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors
    Table 152. Celgene Corporation Streptococcus Pneumoniae Vaccine Product Offered
    Table 153. Celgene Corporation Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 154. Celgene Corporation Main Business
    Table 155. Celgene Corporation Latest Developments
    Table 156. Panacea Biotec Basic Information, Streptococcus Pneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors
    Table 157. Panacea Biotec Streptococcus Pneumoniae Vaccine Product Offered
    Table 158. Panacea Biotec Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 159. Panacea Biotec Main Business
    Table 160. Panacea Biotec Latest Developments
    Table 161. Serum Institute of India Basic Information, Streptococcus Pneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors
    Table 162. Serum Institute of India Streptococcus Pneumoniae Vaccine Product Offered
    Table 163. Serum Institute of India Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 164. Serum Institute of India Main Business
    Table 165. Serum Institute of India Latest Developments
    Table 166. Genentech Basic Information, Streptococcus Pneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors
    Table 167. Genentech Streptococcus Pneumoniae Vaccine Product Offered
    Table 168. Genentech Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 169. Genentech Main Business
    Table 170. Genentech Latest Developments
    Table 171. Genocea Biosciences Basic Information, Streptococcus Pneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors
    Table 172. Genocea Biosciences Streptococcus Pneumoniae Vaccine Product Offered
    Table 173. Genocea Biosciences Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 174. Genocea Biosciences Main Business
    Table 175. Genocea Biosciences Latest Developments
    Table 176. ImmunoBiology Basic Information, Streptococcus Pneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors
    Table 177. ImmunoBiology Streptococcus Pneumoniae Vaccine Product Offered
    Table 178. ImmunoBiology Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 179. ImmunoBiology Main Business
    Table 180. ImmunoBiology Latest Developments
    Table 181. Lupin Basic Information, Streptococcus Pneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors
    Table 182. Lupin Streptococcus Pneumoniae Vaccine Product Offered
    Table 183. Lupin Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 184. Lupin Main Business
    Table 185. Lupin Latest Developments
    Table 186. Nuron Biotech Basic Information, Streptococcus Pneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors
    Table 187. Nuron Biotech Streptococcus Pneumoniae Vaccine Product Offered
    Table 188. Nuron Biotech Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 189. Nuron Biotech Main Business
    Table 190. Nuron Biotech Latest Developments
    Table 191. Biogen Basic Information, Streptococcus Pneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors
    Table 192. Biogen Streptococcus Pneumoniae Vaccine Product Offered
    Table 193. Biogen Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 194. Biogen Main Business
    Table 195. Biogen Latest Developments
    Table 196. Valneva Austria Basic Information, Streptococcus Pneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors
    Table 197. Valneva Austria Streptococcus Pneumoniae Vaccine Product Offered
    Table 198. Valneva Austria Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 199. Valneva Austria Main Business
    Table 200. Valneva Austria Latest Developments
    Table 201. Sinovac Basic Information, Streptococcus Pneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors
    Table 202. Sinovac Streptococcus Pneumoniae Vaccine Product Offered
    Table 203. Sinovac Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 204. Sinovac Main Business
    Table 205. Sinovac Latest Developments
List of Figures
    Figure 1. Picture of Streptococcus Pneumoniae Vaccine
    Figure 2. Streptococcus Pneumoniae Vaccine Report Years Considered
    Figure 3. Research Objectives
    Figure 4. Research Methodology
    Figure 5. Research Process and Data Source
    Figure 6. Global Streptococcus Pneumoniae Vaccine Sales Growth Rate 2017-2028 (K Units)
    Figure 7. Global Streptococcus Pneumoniae Vaccine Revenue Growth Rate 2017-2028 ($ Millions)
    Figure 8. Streptococcus Pneumoniae Vaccine Sales by Region (2021 & 2028) & ($ millions)
    Figure 9. Product Picture of 7 -Valent
    Figure 10. Product Picture of 10 -Valent
    Figure 11. Product Picture of 13 -Valent
    Figure 12. Product Picture of 15 -Valent
    Figure 13. Product Picture of 23 -Valent
    Figure 14. Product Picture of Other
    Figure 15. Global Streptococcus Pneumoniae Vaccine Sales Market Share by Type in 2021
    Figure 16. Global Streptococcus Pneumoniae Vaccine Revenue Market Share by Type (2017-2022)
    Figure 17. Streptococcus Pneumoniae Vaccine Consumed in Children under 2 Years of Age
    Figure 18. Global Streptococcus Pneumoniae Vaccine Market: Children under 2 Years of Age (2017-2022) & (K Units)
    Figure 19. Streptococcus Pneumoniae Vaccine Consumed in Adults over 65 Years of Age
    Figure 20. Global Streptococcus Pneumoniae Vaccine Market: Adults over 65 Years of Age (2017-2022) & (K Units)
    Figure 21. Streptococcus Pneumoniae Vaccine Consumed in Addicted Smokers Between the Ages of 19 and 64
    Figure 22. Global Streptococcus Pneumoniae Vaccine Market: Addicted Smokers Between the Ages of 19 and 64 (2017-2022) & (K Units)
    Figure 23. Streptococcus Pneumoniae Vaccine Consumed in Other
    Figure 24. Global Streptococcus Pneumoniae Vaccine Market: Other (2017-2022) & (K Units)
    Figure 25. Global Streptococcus Pneumoniae Vaccine Sales Market Share by Application (2017-2022)
    Figure 26. Global Streptococcus Pneumoniae Vaccine Revenue Market Share by Application in 2021
    Figure 27. Streptococcus Pneumoniae Vaccine Revenue Market by Company in 2021 ($ Million)
    Figure 28. Global Streptococcus Pneumoniae Vaccine Revenue Market Share by Company in 2021
    Figure 29. Global Streptococcus Pneumoniae Vaccine Sales Market Share by Geographic Region (2017-2022)
    Figure 30. Global Streptococcus Pneumoniae Vaccine Revenue Market Share by Geographic Region in 2021
    Figure 31. Global Streptococcus Pneumoniae Vaccine Sales Market Share by Region (2017-2022)
    Figure 32. Global Streptococcus Pneumoniae Vaccine Revenue Market Share by Country/Region in 2021
    Figure 33. Americas Streptococcus Pneumoniae Vaccine Sales 2017-2022 (K Units)
    Figure 34. Americas Streptococcus Pneumoniae Vaccine Revenue 2017-2022 ($ Millions)
    Figure 35. APAC Streptococcus Pneumoniae Vaccine Sales 2017-2022 (K Units)
    Figure 36. APAC Streptococcus Pneumoniae Vaccine Revenue 2017-2022 ($ Millions)
    Figure 37. Europe Streptococcus Pneumoniae Vaccine Sales 2017-2022 (K Units)
    Figure 38. Europe Streptococcus Pneumoniae Vaccine Revenue 2017-2022 ($ Millions)
    Figure 39. Middle East & Africa Streptococcus Pneumoniae Vaccine Sales 2017-2022 (K Units)
    Figure 40. Middle East & Africa Streptococcus Pneumoniae Vaccine Revenue 2017-2022 ($ Millions)
    Figure 41. Americas Streptococcus Pneumoniae Vaccine Sales Market Share by Country in 2021
    Figure 42. Americas Streptococcus Pneumoniae Vaccine Revenue Market Share by Country in 2021
    Figure 43. United States Streptococcus Pneumoniae Vaccine Revenue Growth 2017-2022 ($ Millions)
    Figure 44. Canada Streptococcus Pneumoniae Vaccine Revenue Growth 2017-2022 ($ Millions)
    Figure 45. Mexico Streptococcus Pneumoniae Vaccine Revenue Growth 2017-2022 ($ Millions)
    Figure 46. Brazil Streptococcus Pneumoniae Vaccine Revenue Growth 2017-2022 ($ Millions)
    Figure 47. APAC Streptococcus Pneumoniae Vaccine Sales Market Share by Region in 2021
    Figure 48. APAC Streptococcus Pneumoniae Vaccine Revenue Market Share by Regions in 2021
    Figure 49. China Streptococcus Pneumoniae Vaccine Revenue Growth 2017-2022 ($ Millions)
    Figure 50. Japan Streptococcus Pneumoniae Vaccine Revenue Growth 2017-2022 ($ Millions)
    Figure 51. South Korea Streptococcus Pneumoniae Vaccine Revenue Growth 2017-2022 ($ Millions)
    Figure 52. Southeast Asia Streptococcus Pneumoniae Vaccine Revenue Growth 2017-2022 ($ Millions)
    Figure 53. India Streptococcus Pneumoniae Vaccine Revenue Growth 2017-2022 ($ Millions)
    Figure 54. Australia Streptococcus Pneumoniae Vaccine Revenue Growth 2017-2022 ($ Millions)
    Figure 55. Europe Streptococcus Pneumoniae Vaccine Sales Market Share by Country in 2021
    Figure 56. Europe Streptococcus Pneumoniae Vaccine Revenue Market Share by Country in 2021
    Figure 57. Germany Streptococcus Pneumoniae Vaccine Revenue Growth 2017-2022 ($ Millions)
    Figure 58. France Streptococcus Pneumoniae Vaccine Revenue Growth 2017-2022 ($ Millions)
    Figure 59. UK Streptococcus Pneumoniae Vaccine Revenue Growth 2017-2022 ($ Millions)
    Figure 60. Italy Streptococcus Pneumoniae Vaccine Revenue Growth 2017-2022 ($ Millions)
    Figure 61. Russia Streptococcus Pneumoniae Vaccine Revenue Growth 2017-2022 ($ Millions)
    Figure 62. Middle East & Africa Streptococcus Pneumoniae Vaccine Sales Market Share by Country in 2021
    Figure 63. Middle East & Africa Streptococcus Pneumoniae Vaccine Revenue Market Share by Country in 2021
    Figure 64. Egypt Streptococcus Pneumoniae Vaccine Revenue Growth 2017-2022 ($ Millions)
    Figure 65. South Africa Streptococcus Pneumoniae Vaccine Revenue Growth 2017-2022 ($ Millions)
    Figure 66. Israel Streptococcus Pneumoniae Vaccine Revenue Growth 2017-2022 ($ Millions)
    Figure 67. Turkey Streptococcus Pneumoniae Vaccine Revenue Growth 2017-2022 ($ Millions)
    Figure 68. GCC Country Streptococcus Pneumoniae Vaccine Revenue Growth 2017-2022 ($ Millions)
    Figure 69. Manufacturing Cost Structure Analysis of Streptococcus Pneumoniae Vaccine in 2021
    Figure 70. Manufacturing Process Analysis of Streptococcus Pneumoniae Vaccine
    Figure 71. Industry Chain Structure of Streptococcus Pneumoniae Vaccine
    Figure 72. Channels of Distribution
    Figure 73. Distributors Profiles
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
Global Streptococcus Pneumoniae Vaccine Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Global Streptococcus Pneumoniae Vaccine Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Global Streptococcus Pneumoniae Vaccine Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports